Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
DaShenLin Pharmaceutical Group Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 4/6
DaShenLin Pharmaceutical Group has a total shareholder equity of CN¥8.4B and total debt of CN¥3.0B, which brings its debt-to-equity ratio to 35.8%. Its total assets and total liabilities are CN¥25.5B and CN¥17.1B respectively. DaShenLin Pharmaceutical Group's EBIT is CN¥1.5B making its interest coverage ratio 9.4. It has cash and short-term investments of CN¥5.1B.
Anahtar bilgiler
35.8%
Borç/özkaynak oranı
CN¥3.00b
Borç
| Faiz karşılama oranı | 9.4x |
| Nakit | CN¥5.06b |
| Eşitlik | CN¥8.37b |
| Toplam yükümlülükler | CN¥17.12b |
| Toplam varlıklar | CN¥25.49b |
Son finansal sağlık güncellemeleri
Recent updates
Take Care Before Diving Into The Deep End On DaShenLin Pharmaceutical Group Co., Ltd. (SHSE:603233)
Sep 30
DaShenLin Pharmaceutical Group Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Sep 03DaShenLin Pharmaceutical Group (SHSE:603233) May Have Issues Allocating Its Capital
Aug 20Not Many Are Piling Into DaShenLin Pharmaceutical Group Co., Ltd. (SHSE:603233) Stock Yet As It Plummets 27%
Jun 17Does DaShenLin Pharmaceutical Group (SHSE:603233) Have A Healthy Balance Sheet?
Jun 09Are Investors Undervaluing DaShenLin Pharmaceutical Group Co., Ltd. (SHSE:603233) By 30%?
May 21Some May Be Optimistic About DaShenLin Pharmaceutical Group's (SHSE:603233) Earnings
May 06Investors Could Be Concerned With DaShenLin Pharmaceutical Group's (SHSE:603233) Returns On Capital
Apr 09Lacklustre Performance Is Driving DaShenLin Pharmaceutical Group Co., Ltd.'s (SHSE:603233) Low P/E
Mar 17Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 603233's short term assets (CN¥11.5B) do not cover its short term liabilities (CN¥12.3B).
Uzun Vadeli Yükümlülükler: 603233's short term assets (CN¥11.5B) exceed its long term liabilities (CN¥4.8B).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 603233 has more cash than its total debt.
Borcun Azaltılması: 603233's debt to equity ratio has increased from 35.7% to 35.8% over the past 5 years.
Borç Kapsamı: 603233's debt is well covered by operating cash flow (115.6%).
Faiz Kapsamı: 603233's interest payments on its debt are well covered by EBIT (9.4x coverage).